Printer-friendly versionSend to friend

Leadership Council

The LSI Leadership Council is a group of biomedical industry leaders, venture capitalists, and government officials. The council advises and supports the LSI leadership and faculty.

Members

• Raj Alva - Managing Director, Lazard Freres
• Mary Cambell - Managing Director, EDF Ventures
• David Canter - Director of Health Care Research of U-M William Davidson Institute and former Senior Vice President, Global Research and Development, Pfizer, Inc.
• Michael Finney - President and CEO, Ann Arbor SPARK
• Jim Hackett - President and CEO, Steelcase, Inc.
• Bill Hall - Chairman and CEO, Procyon Technologies
• Shiraz Ladiwala - Vice President of Strategy and Business Development, Thermo Fisher Scientific
• Julius Li - CEO, AutekBio Inc.
• Ernie Ludy - Founder; Former Chairman and CEO, The Medstat Group
• Greg Margolies - Senior Partner and Head of Capital Markets, Ares Management LLC
• Joel Martin - President and CEO of Altair Therapeutics
• Paul Meister - Chief executive officer and co-founder of Liberty Lane Partners
• Roger Newton - President, Esperion Therapeutics
• Jim Niedel - Venture Partner, Healthcare Technology, Sprout Group
• John Osborn - Exec. VP, GC & Secretary for Cephalon Inc.
• Craig Parker (Chair) - Senior VP, Finance and Corporate Development & Chief Financial Officer, Proteolix, Inc.
• Dr. Joe Schwarz - Former US Representative, 7th Congressional District
• Greg Simon - Senior VP, Worldwide Policy, Pfizer, Inc.
• Michael Staebler - Partner, Pepper Hamilton LLP
• David Walt - Robinson Professor of Chemistry, Tufts University. Founder and Director of Illumina, Inc.
• Wendell Wierenga - Executive Vice President of R & D Ambit Biosciences Corporation